Dolby Laboratories

DLB62

$81.98arrow_drop_up15.59%$11.05

DLB62

$81.98

arrow_drop_up15.59%$11.05

Performance History

Key Stats
Open	$75.50
Prev. Close	$70.91
EPS	2.18

Next Earnings Date	Dec 2, 2024

	LOW	HIGH
Day Range	75.00	82.39
52 Week Range	66.35	90.06

Ratios







EPS	2.18

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Dolby Laboratories (DLB)

Dolby Laboratories Inc (DLB) is a leading audio technology company that specializes in developing and delivering immersive audio experiences to consumers and professionals worldwide. The company was founded in 1965 by Ray Dolby, a renowned engineer and inventor, and has since grown to become a global leader in audio innovation. With a rich history of groundbreaking advancements, Dolby has revolutionized the way people experience sound in movies, music, gaming, and more.

Dolby's stock price history has been quite impressive, with consistent growth over the years. The company's stock has seen significant increases in value, reflecting its strong financial performance and market dominance. Investors have been attracted to Dolby's track record of innovation and its ability to stay ahead of the competition in a rapidly evolving audio industry.

Websitecall_made

Sector: Industrials
Industry: Specialty Business Services
CEO: Mr. Kevin J. Yeaman
Headquarters: San Francisco
Employees: 2336
Exchange: NYSE

Keep an eye on Dolby Laboratories

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is the market capitalization of Dolby Laboratories (DLB)?

Dolby Laboratories (DLB) has a market capitalization of $7.82B. The average daily trading volume is 80.7, indicating the stock's liquidity and investor engagement.

help

What is Dolby Laboratories 's (DLB) price per share?

The current price per share for Dolby Laboratories (DLB) is $81.98. The stock has seen a price change of $11.06 recently, indicating a 15.59% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Dolby Laboratories (DLB)?

For Dolby Laboratories (DLB), the 52-week high is $90.06, which is 9.86% from the current price. The 52-week low is $66.35, the current price is 23.56% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Dolby Laboratories (DLB) a growth stock?

Dolby Laboratories (DLB) has shown an average price growth of -7.34% over the past three years. It has received a score of 40 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Dolby Laboratories as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Dolby Laboratories (DLB) stock price performance year to date (YTD)?

As of the latest data, Dolby Laboratories (DLB) has a year-to-date price change of -4.36%. Over the past month, the stock has experienced a price change of 10.4%. Over the last three months, the change has been 13.12%. Over the past six months, the figure is -0.86%. Looking at a longer horizon, the five-year price change stands at 17.27%.

help

Is Dolby Laboratories (DLB) a profitable company?

Dolby Laboratories (DLB) has a net income of $191.74M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 88.41% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 14.15% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $1.01B, although specific revenue growth data is currently not available. The gross profit is $892.17M. Operating income is noted at $219.25M. Furthermore, the EBITDA is $366.75M.